R&D and production of APIs and advanced intermediates for cardiovascular and cerebrovascular drugs and anti-cancer drugs; R&D and production of innovative drugs.


Providing customers with sound, impartial and accurate bioanalysis service will become a new business highlight of the Group.


Weijie Pharmaceuticals has a production base at Tianjin economic and technical development zone. The product system we applied has been certificated by FDA and met the requirements of Good Manufacture Practice of Medical Products and cGMP

Established in 2004, Weijie Pharmaceuticals is a pharmaceutical company whose core businesses are research and development of active pharmaceutical ingredients and high-grade intermediates and customized production. 

Market is infinite, so is the goal; create a famous brand, dedicate superior medicine. Weijie Pharmaceuticals will aim at “preserving raw materials, making competitive preparations and entering the mainstream”, center on stable and effective supply of special active pharmaceutical ingredients and key intermediate with R&D and production of preparations as supports, and strive to forge a competitive pharmaceutical enterprise by increasing capacity, innovating business model and advancing coordinated growth of various industries, to provide global clients with better products and services and to continue to create new glories in future development. 

Company News
Weijie Pharmaceutical has successfully passed its third US FDA inspection
Tianjin Weijie Pharmaceutical has successfully passed its third US FDA inspection. The inspection took place from 8thto 12thJanuary. The entire qualit…
剑网3pvp pve赚钱 证券投资股票分析报告 股票配资来大圣配资 甘肃11选5平台 快乐8登录入口 印度股票指数 新疆风采喜乐彩开奖号 黑龙江6 1开奖结果 25522股票配资 芸泓配资 2020年年香港今晚开奖结果